Jacob Chacko - PRESIDENT AND CEO, Director at Oric Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Issuer Symbol
ORIC on Nasdaq
All Insider Reports
All Insider Reports

Jacob Chacko - trading volume in the past year for Oric Pharmaceuticals, Inc.

Holdings reported by Jacob Chacko for Oric Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 581,711 $5,270,301 $9.06 16 Dec 2025 Direct
Restricted Stock Unit 112,500 $828,130 $8.28 02 Jan 2026 Direct Common Stock
Stock Option (right to buy) 675,000 02 Jan 2026 Direct Common Stock

Transactions reported by Jacob Chacko for Oric Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.